Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Munson

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Progress in Clinical and Biological Research|January 1, 1984
Modification of the pharmacokinetics of MVE-2 to enhance its effects on host resistanceG M Shopp, A E Munson
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1985
Role of alpha adrenoceptor activation in modulating the murine primary antibody response in vitroV M Sanders, A E Munson
Methods in Molecular Biology (Clifton, N.J.)|May 20, 2000
Natural killer cells and immunotoxicologyA E Munson, K E Phillips
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factorsL A Burns, A E Munson
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Potentiation of the in vitro T-dependent antibody response by the B subunit of cholera toxinK S Campbell, A E Munson
Journal of Leukocyte Biology|July 1, 1984
Suppression of the in vitro specific antibody response by 12-O-tetradecanoylphorbol-13-acetate (TPA) in the mouseG M Shopp, A E Munson
Toxicology and Applied Pharmacology|August 1, 1997
2'3'-Dideoxyinosine inhibits the humoral immune response in female B6C3F1 mice by targeting the B lymphocyteK E Phillips, A E Munson
Toxicology and Applied Pharmacology|July 1, 1981
In vitro inhibition of the primary antibody response to sheep erythrocytes by cyclophosphamideA N Tucker, A E Munson
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposureL A Burns, A E Munson
Biometrics|March 1, 1981
Estimation of the median lethal dose when responses within a little are correlatedA C Segreti, A E Munson
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Progress in Clinical and Biological Research|January 1, 1984
Modification of the pharmacokinetics of MVE-2 to enhance its effects on host resistanceG M Shopp, A E Munson
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1985
Role of alpha adrenoceptor activation in modulating the murine primary antibody response in vitroV M Sanders, A E Munson
Methods in Molecular Biology (Clifton, N.J.)|May 20, 2000
Natural killer cells and immunotoxicologyA E Munson, K E Phillips
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factorsL A Burns, A E Munson
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Potentiation of the in vitro T-dependent antibody response by the B subunit of cholera toxinK S Campbell, A E Munson
Journal of Leukocyte Biology|July 1, 1984
Suppression of the in vitro specific antibody response by 12-O-tetradecanoylphorbol-13-acetate (TPA) in the mouseG M Shopp, A E Munson
Toxicology and Applied Pharmacology|August 1, 1997
2'3'-Dideoxyinosine inhibits the humoral immune response in female B6C3F1 mice by targeting the B lymphocyteK E Phillips, A E Munson
Toxicology and Applied Pharmacology|July 1, 1981
In vitro inhibition of the primary antibody response to sheep erythrocytes by cyclophosphamideA N Tucker, A E Munson
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposureL A Burns, A E Munson
Biometrics|March 1, 1981
Estimation of the median lethal dose when responses within a little are correlatedA C Segreti, A E Munson
Pageof 13